These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
536 related articles for article (PubMed ID: 25369881)
1. Doping in sport: effects, harm and misconceptions. Birzniece V Intern Med J; 2015 Mar; 45(3):239-48. PubMed ID: 25369881 [TBL] [Abstract][Full Text] [Related]
2. Growth hormone and physical performance. Birzniece V; Nelson AE; Ho KK Trends Endocrinol Metab; 2011 May; 22(5):171-8. PubMed ID: 21420315 [TBL] [Abstract][Full Text] [Related]
3. Use of doping agents, particularly anabolic steroids, in sports and society. Sjöqvist F; Garle M; Rane A Lancet; 2008 May; 371(9627):1872-82. PubMed ID: 18514731 [TBL] [Abstract][Full Text] [Related]
4. The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized trial. Meinhardt U; Nelson AE; Hansen JL; Birzniece V; Clifford D; Leung KC; Graham K; Ho KK Ann Intern Med; 2010 May; 152(9):568-77. PubMed ID: 20439575 [TBL] [Abstract][Full Text] [Related]
5. Effects of androgenic-anabolic steroids in athletes. Hartgens F; Kuipers H Sports Med; 2004; 34(8):513-54. PubMed ID: 15248788 [TBL] [Abstract][Full Text] [Related]
6. Position stand on androgen and human growth hormone use. Hoffman JR; Kraemer WJ; Bhasin S; Storer T; Ratamess NA; Haff GG; Willoughby DS; Rogol AD J Strength Cond Res; 2009 Aug; 23(5 Suppl):S1-S59. PubMed ID: 19620932 [TBL] [Abstract][Full Text] [Related]
7. Drugs and sport. Research findings and limitations. Clarkson PM; Thompson HS Sports Med; 1997 Dec; 24(6):366-84. PubMed ID: 9421862 [TBL] [Abstract][Full Text] [Related]
8. Growth hormone administration: is it safe and effective for athletic performance. Birzniece V; Nelson AE; Ho KK Endocrinol Metab Clin North Am; 2010 Mar; 39(1):11-23, vii. PubMed ID: 20122446 [TBL] [Abstract][Full Text] [Related]
9. [The use of drugs to improve athletic performance]. Kuipers H; Hartgens F Ned Tijdschr Geneeskd; 1997 Oct; 141(41):1965-8. PubMed ID: 9550746 [TBL] [Abstract][Full Text] [Related]
10. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes. Deligiannis A; Björnstad H; Carre F; Heidbüchel H; Kouidi E; Panhuyzen-Goedkoop NM; Pigozzi F; Schänzer W; Vanhees L; Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):687-94. PubMed ID: 17001206 [TBL] [Abstract][Full Text] [Related]
11. [Growth hormone and IGF-1 as doping agents in competitive sport]. Jóźków P; Medraś M Endokrynol Pol; 2009; 60(5):389-94. PubMed ID: 19885810 [TBL] [Abstract][Full Text] [Related]
12. MECHANISMS IN ENDOCRINOLOGY: Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. Nieschlag E; Vorona E Eur J Endocrinol; 2015 Aug; 173(2):R47-58. PubMed ID: 25805894 [TBL] [Abstract][Full Text] [Related]
13. Androgen abuse in athletes: detection and consequences. Basaria S J Clin Endocrinol Metab; 2010 Apr; 95(4):1533-43. PubMed ID: 20139230 [TBL] [Abstract][Full Text] [Related]
15. Abuse of anabolic androgenic steroids and related substances in sport and exercise. Bahrke MS; Yesalis CE Curr Opin Pharmacol; 2004 Dec; 4(6):614-20. PubMed ID: 15525553 [TBL] [Abstract][Full Text] [Related]
16. Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk? Tentori L; Graziani G Pharmacol Res; 2007 May; 55(5):359-69. PubMed ID: 17349798 [TBL] [Abstract][Full Text] [Related]
17. [Use of androgenic anabolic steroids before and during the Olympic Games: less but has not died out]. de Ronde W Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1820-4. PubMed ID: 18783159 [TBL] [Abstract][Full Text] [Related]